Zealand Pharma Interim Report First Quarter 2020
Zealand Pharma held a conference call on May 14, 2020 at 4 pm CEST (10 am EDT) following the announcement of results for the first quarter of 2020.
Presenting during the call were President and Chief Executive Officer Emmanuel Dulac, Senior Vice President and Chief Financial Officer Matt Dallas, and Executive Vice President and Chief Medical Officer Adam Steensberg.
Download report
Zealand Pharma interim report for Q1 2020
Replay webcast
https://edge.media-server.com/mmc/p/if6x6hq7
Download presentation
Zealand Pharma Q1 2020 webcast